New Guidance for High-Risk Groups The U.S. Food and Drug Administration (FDA) announced on Tuesday an amendment to the emergency use authorizations for Pfizer-BioNTech and Moderna bivalent COVID-19 vaccines. This regulatory shift permits adults aged 65 and older, as well as specific immunocompromised individuals, to receive an additional dose of the updated booster, providing an…
Federal health officials at the Centers for Disease Control and Prevention (CDC) released updated COVID-19 vaccination guidelines this week, recommending that all individuals aged six months and older receive the most recent 2024-2025 formula to bolster immunity against evolving viral variants. This shift comes as public health experts aim to synchronize annual COVID-19 prevention efforts…
Discover how pediatric Covid-19 boosters could prevent thousands of hospitalizations and millions of missed school days for children.
